Opioids

Discussions Archivos Imágenes Videos Enlaces Eventos Knowledge Share Todo(s)

Source: Hooker, S. A., Crain, A. L., LaFrance, A. B., Kane, S., Fokuo, J. K., Bart, G., & Rossom, R. C. (2023). A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians. Addiction Science & Clinical Practice, 18(1), 1-10...

A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians_0.pdf

Source: Washburn LT, Franck KL, Upendram S and Yenerall JN (2022) Cooperative Extension professionals’ knowledge and attitudes toward the opioid epidemic: Implications for capacity development and outreach. Front. Psychiatry 13:958335. doi: 10.3389/fpsyt.2022.958335 Introduction: Worsening of the...

Cooperative Extension professionals' knowledge and attitudes toward the opioid epidemic Implications for capacity development and outreach.pdf

Source: Dolan AR, Goldberg EB, Cannuscio CC, et al. Patient Perceptions About Opioid Risk Communications Within the Context of a Randomized Clinical Trial. JAMA Netw Open. 2022;5(8):e2227650. doi:10.1001/jamanetworkopen.2022.27650 Key Points Question What can be learned about patient experiences...

Patient Perceptions About Opioid Risk Communications Within the Context of a Randomized Clinical Trial.pdf

Source: Beaudoin FL, Jacka BP, Li Y, et al. Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(8):e2225582. doi:10.1001/jamanetworkopen.2022.25582 Key Points Question Can peer-led...

Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose_0.pdf

Source: Andraka-Christou, B., Page, C., Schoebel, V. et al. Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants. Addict Sci Clin Pract 17, 43 (2022). https://doi.org/10.1186/s13722-022-00321-6 Abstract Background Medications for opioid use disorder...

Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants.pdf

Description: This webinar is linked to the latest bundle of EMCDDA miniguides which focus on responding to drug-related harms. It aims to provide an insight into the current situation regarding drug-related deaths in Europe and responses to them. Speakers will briefly present the situations they...

Source: Hodgins, D. C., Budd, M., Czukar, G., Dubreucq, S., Jackson, L. A., Rush, B., ... & Cameron Wild, T. (2022). Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice. The Canadian Journal of Psychiatry...

Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs A National Survey of Policy, Attitudes, and Practice.pdf

Source: Pasman, E., Kollin, R., Broman, M. et al. Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities. Addict Sci Clin Pract 17, 35 (2022). https://doi.org/10.1186/s13722-022-00316-3 Abstract Background Though methadone has been shown to...

Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities_0.pdf

Source: Le TT, Park S, Choi M, et al. Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease. BMJ Open Respiratory Research 2020;7:e000483. doi: 10.1136/bmjresp-2019-000483 Abstract Background Opioids and...

Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease.pdf

Source: Shorter, G. W., Harris, M., McAuley, A., Trayner, K. M., & Stevens, A. (2022). The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation. International Journal of Drug Policy, 104, 103670. Abstract Background The United Kingdom (UK) is currently...

The United Kingdom's first unsanctioned overdose prevention site A proof-of-concept evaluation.pdf

Opioid Facts and Figures, recorded 3-June-2022. Presented by Lauran Wirf, DO: Addiction Medicine Fellow; University of Colorado School of Medicine; Denver, Colorado. With the increasing prevalence of illicit fentanyl, it is important for healthcare providers to understand the new hurdles they may...

Source: Yang Lim, T, et al. (2022). Modeling the evolution of the US opioid crisis for national policy development. Proceedings of the National Academy of Sciences, 119(23). https://www.pnas.org/doi/10.1073/pnas.2115714119 Significance The opioid crisis remains one of the greatest public health...

Modeling the evolution of the US opioid crisis for national policy development.pdf

Source: Heikkinen, M., Taipale, H., Tanskanen, A., Mittendorfer‐Rutz, E., Lähteenvuo, M., & Tiihonen, J. (2022). Real‐world effectiveness of pharmacological treatments of opioid use disorder in a national cohort. Addiction. Abstract Aim To investigate the real-world effectiveness of pharmacological...

Real-world effectiveness of pharmacological treatments of opioid use disorder in a national cohort.pdf

Source: Janzow, G. E., Harding, C., Flores, M., Borodovsky, J., Steinkamp, J., Marsch, L. A., & Schuman-Olivier, Z. (2022). Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized...

Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment Lessons learned from a pilot randomized controlled trial.pdf

Upcoming Events

There aren't any upcoming events

All Events

A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians

Cooperative Extension professionals' knowledge and attitudes toward the opioid epidemic: Implications for capacity development and outreach

Patient Perceptions About Opioid Risk Communications Within the Context of a Randomized Clinical Trial

Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose A Randomized Clinical Trial

Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants

EMCDDA webinar: Drug-related deaths in Europe, current challenges and implications for responses

Background

Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice

Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities

Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease

The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation

Opioid Facts and Figures

Modeling the evolution of the US opioid crisis for national policy development

Fondo

Real-world effectiveness of pharmacological treatments of opioid use disorder in a national cohort

Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial

Upcoming Events